- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01347021
Compare Sacrospinous Fixation Versus High Uterosacral Ligament Fixation for Uterus Vaginal Prolapse III/IV
May 3, 2011 updated by: Federal University of São Paulo
Sacrospinous Colpopexy Versus High Uterosacral Colpopexy in the Treatment of Genital Prolapse Grade III/IV in Women With Uterus
The purpose of this study is to compare the vaginal sacrospinous colpopexy and high uterosacral colpopexy in the treatment of genital prolapse grade III/IV in women with uterus.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Hysterectomy is often the traditional approach for women with uterovaginal prolapse.
However, hysterectomy alone does not address the underlying problem of deficient apical support.
Surgical options for patients with apical prolapse include transvaginal suspension procedures using pelvic structures for fixation, such as the sacrospinous ligament or uterosacral ligaments.The objective of this study is to compare the sacrospinous fixation with high uterosacral in the treatment of uterine prolapse POP-Q stage 3 or 4 in terms of recurrence of prolapse,quality of life,complications,post-operative recovery, hospital stay.
Study Type
Interventional
Enrollment (Actual)
51
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
São Paulo, Brazil, 04023062
- Federal University of São Paulo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
48 years to 83 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- pelvic prolapse III/IV
- counselling and informed consent
Exclusion Criteria:
- abnormal cervical smears
- abnormal ultrasound findings of uterus or ovaries or abnormal uterine bleeding
- pelvic radiotherapy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: sacrospinous, pelvic prolapse.
Women with pelvic prolapse grade III/IV were randomly allocated to the sacrospinous colpopexy (25 women) or high uterosacral (26 women)
|
Women with uterine prolapse grade III or IV were randomly allocated to the sacrospinous colpopexy or high uterosacral colpopexy with vaginal hysterectomy.Before the surgery P-Qol questionnaire were completed and urogynecological examination include de POP-Q system was done.
All patients underwent clinical check-ups 1, 6 and 12 months postoperatively.
Each check-up included clinical examination and questionnaire.
Other Names:
|
Active Comparator: uterosacral , pelvic prolapse.
Women with pelvic prolapse grade III/IV were randomly allocated to the sacrospinous colpopexy (25 women) or high uterosacral (26 women)
|
Women with uterine prolapse grade III or IV were randomly allocated to the sacrospinous colpopexy or high uterosacral colpopexy with vaginal hysterectomy.Before the surgery P-Qol questionnaire were completed and urogynecological examination include de POP-Q system was done.
All patients underwent clinical check-ups 1, 6 and 12 months postoperatively.
Each check-up included clinical examination and questionnaire.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pelvic Organ Prolapse Quantification (POPQ) at 12 months follow-up
Time Frame: one year
|
Quantification of pelvic organ prolapse, according to the Pelvic Organ Prolapse Quantification system (POPQ), as standardized by the International Continence Society.
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
subjective improvement in quality of life measured by Quality-of-Life Questionnaire (P-QoL)after surgery at 12 months follow-up
Time Frame: one year
|
one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Manoel C B Girão, MD, Federal University of São Paulo
- Principal Investigator: Sergio B Martins, md, Federal University of São Paulo
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2006
Primary Completion (Actual)
December 1, 2009
Study Completion (Anticipated)
May 1, 2011
Study Registration Dates
First Submitted
April 25, 2011
First Submitted That Met QC Criteria
May 3, 2011
First Posted (Estimate)
May 4, 2011
Study Record Updates
Last Update Posted (Estimate)
May 4, 2011
Last Update Submitted That Met QC Criteria
May 3, 2011
Last Verified
May 1, 2006
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- unifespcep0833/05
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Uterovaginal Prolapse
-
Zeynep Kamil Maternity and Pediatric Research and...RecruitingLaparoscopy | Prolapse Uterovaginal | Prolapse BladderTurkey
-
Centre Hospitalier Universitaire de NīmesUniversity Hospital, Lille; Centre Hospitalier de La Rochelle; Kremlin-Bicetre... and other collaboratorsRecruitingProlapse; Female | Prolapse Uterovaginal | Prolapse; CervixFrance
-
Seoul National University HospitalUnknownUterovaginal Prolapse | HysteropexyKorea, Republic of
-
Ain Shams UniversityCompletedUterovaginal and Vaginal Vault ProlapseEgypt
-
University of Milano BicoccaRecruitingSurgery--Complications | Ureteral Injury | Uterovaginal ProlapseItaly
-
NICHD Pelvic Floor Disorders NetworkBoston Scientific CorporationActive, not recruiting
-
Alexander KhitaryanRecruitingRectal Prolapse | Rectocele; Female | Rectocele and Incomplete Uterine Prolapse | Rectocele and Complete Uterovaginal ProlapseRussian Federation
-
Charles University, Czech RepublicRecruitingPelvic Organ Prolapse | Cystocele | Cystocele and Incomplete Uterovaginal ProlapseCzechia, Slovakia
-
Atlantic Health SystemRecruitingPelvic Organ Prolapse | Cystocele | Vaginal Vault Prolapse | Uterovaginal ProlapseUnited States
-
Rennes University HospitalRecruiting
Clinical Trials on sacrospinous colpopexy versus high uterosacral colpopexy
-
Kaiser PermanenteMassachusetts General HospitalUnknownProlapse of Vaginal Vault After HysterectomyUnited States